Hi everyone,
Hope this message finds you all well. I haven’t posted much lately but I do check in once in a while. The following was sent to me thru e-mail from aamds foundation. I hope you find it helpful:
November 2005
Oral Iron Chelator Exjade® Approved by U.S. Food and Drug Administration (FDA)
The AA&MDSIF applauds the FDA’s approval of Novartis’ Exjade® (deferasirox), announced Thursday, November 3rd. Exjade® is the first and only once-daily oral iron chelator approved for the treatment of chronic iron overload due to blood transfusions in adults and children age two and older.
Exjade® is administered as a drink (the tablets are dispersed in a glass of orange juice, apple juice, or water), compared to the current standard of care, which often requires a subcutaneous infusion lasting eight to 12 hours per night, for five to seven nights a week for as long as the patient continues to receive blood transfusions or has excess iron within the body. As a result, many patients may have stopped or avoided iron chelation therapy, thus risking the toxic effects of iron overload.
“Yesterday’s approval of Exjade® provides our transfusion-dependent patients with a welcome new treatment option for the potentially fatal effects caused by iron overload,” said Marilyn Baker, Executive Director of AA&MDSIF.
To learn more about Exjade®, patients and physicians in the U.S. can call 888.669.6682. To learn more about ongoing Exjade clinical trials, health care providers can call either 800.340.6843 in the U.S., or +44 (0) 1506 814899 outside the U.S.
.
